Clinical Trials · NCT01511198
Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 223
- Start date
- Feb 2001
- Locations
- 39 sites, United States
- Primary endpoint
- Body weight